首页> 外文期刊>Iranian Journal of Microbiology >Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate
【24h】

Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable Haemophilus influenzae using MPLA-CpG adjuvant as a vaccine candidate

机译:使用MPLA-CPG佐剂作为疫苗候选的非缺乏血液血流病患者外膜囊泡(OMV)免疫应答的评价

获取原文
           

摘要

Background and Objectives: Nontypeable Haemophilus influenzae (NTHi) are major causes of non-invasive infections, including otitis media and sinusitis and it can also contribute to respiratory infections of all ages. Currently, there is no licensed vaccine against NTHi commercially available. Many studies have been conducted on the use of OMV as a vaccine against NTHi. The purpose of this study is to achieve an immunogenic vaccine against NTHi. Materials and Methods: In this study, standard OMV Haemophilus (ATCC49766) with adjuncts CpG and MPLA was used and after infusion into BALB/c mice, the levels of antibodies and cytokines were measured on serum of immunized mice. Results: The results showed that total IgG antibody and IgG1 and IgG2a isotypes in OMV immunized mice with mixture of CpG-MPLA adjuvant had a significant increase. Also, the results of cytokines (IL-10, IL-4 and IFN-γ) showed that IL-4 had the highest rate. Conclusion: These findings indicate that OMVs derived from NTHi strains have a high potential to act as a vaccine against NTHi infections.
机译:背景和目标:无滴血性嗜血杆菌(Nthi)是非侵入性感染的主要原因,包括中耳炎和鼻窦炎,它也可以有助于所有年龄段的呼吸道感染。目前,没有对NTHI商购的许可疫苗。已经对使用OMV作为针对NTHI的疫苗进行了许多研究。本研究的目的是实现针对NTHI的免疫原性疫苗。材料和方法:在本研究中,使用具有辅助CPG和MPLA的标准OMV血液渗(ATCC49766),并在输注到BALB / C小鼠后,测量抗体和细胞因子的水平在免疫小鼠的血清上测量。结果:结果表明,通过CpG-MPLA佐剂混合物的OMV免疫小鼠中的IgG抗体和IgG1和IgG2a同种型具有显着增加。而且,细胞因子(IL-10,IL-4和IFN-γ)的结果表明IL-4具有最高速率。结论:这些发现表明,来自Nthi菌株的OMV具有很大的潜力,可作为患有针对NTHI感染的疫苗。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号